Depletion of Alveolar Macrophages during Influenza Infection Facilitates Bacterial Superinfections

Cited by (394)

Items 201–300 of 394

1. Influenza A induces dysfunctional immunity and death in MeCP2-overexpressing mice
   James C. Cronk, Jasmin Herz, Taeg S. Kim, Antoine Louveau, Emily K. Moser, Ashish Kumar Sharma, Igor Smirnov, Kenneth S. K. Tung, Thomas J. Braciale, Jonathan Kipnis · 2017 · JCI Insight
2. Innate immune responses at the asymptomatic stage of influenza A viral infections of Streptococcus pneumoniae colonized and non-colonized mice
   Fabian Cuypers, Alexander Schäfer, Sebastian B. Skorka, Surabhi Surabhi, Lea A. Tölken, Antje D. Paulikat, Thomas P. Kohler, Saskia A. Otto, Thomas C. Mettenleiter, Sven Hammerschmidt et al. · 2021 · Scientific Reports
3. The Contribution of Viral Proteins to the Synergy of Influenza and Bacterial Co-Infection
   Miriam Mikušová, Karolína Tomčíková, Katarína Briestenská, František Kostolanský, Eva Varečková · 2022 · Viruses
4. The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019
   Dijoia B. Darden, Russell B. Hawkins, Shawn D. Larson, Nicole M. Iovine, Donald S. Prough, Philip Alexander Efron · 2020 · Critical Care Explorations
5. Mechanistic Basis of Super-Infection: Influenza-Associated Invasive Pulmonary Aspergillosis
   Keven Mara Robinson · 2022 · Journal of Fungi
6. Mitochondrial cyclophilin D promotes disease tolerance by licensing NK cell development and IL-22 production against influenza virus
   Jeffrey Downey, Haley E. Randolph, Erwan Pernet, Kim A. Tran, Shabaana A. Khader, Irah L. King, Luis Bruno Barreiro, Maziar Divangahi · 2022 · Cell Reports
7. Influenza A–induced cystic fibrosis transmembrane conductance regulator dysfunction increases susceptibility to Streptococcus pneumoniae
   Erin Y. Earnhardt, Jennifer L. Tipper, Adonis D’Mello, Ming‐Yuan Jian, Elijah S. Conway, James A. Mobley, Carlos Javier Orihuela, Hervé Tettelin, Kevin S. Harrod · 2023 · JCI Insight
8. Asthma Increases Susceptibility to Heterologous but Not Homologous Secondary Influenza
   Yoichi Furuya, Sean Roberts, Gregory J. Hurteau, Alan M. Sanfilippo, Rachael Racine, Dennis W. Metzger · 2014 · Journal of Virology
9. Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and Dexamethasone
   Heba H. Mostafa, Peter Vogel, Ashok Srinivasan, Charles J. Russell · 2016 · PLoS Pathogens
10. Interrupting the Conversation: Implications for Crosstalk Between Viral and Bacterial Infections in the Asthmatic Airway
    Jodie Ackland, Alastair Watson, Tom M. A. Wilkinson, Karl J. Staples · 2021 · Frontiers in Allergy
11. Viral PB1-F2 and host IFN-γ guide ILC2 and T cell activity during influenza virus infection
    Tarani Kanta Barman, Victor C. Huber, Jesse L. Bonin, Danielle Califano, Sharon L. Salmon, Andrew N. J. McKenzie, Dennis W. Metzger · 2022 · Proceedings of the National Academy of Sciences
12. K63-Linked Polyubiquitination on TRAF6 Regulates LPS-Mediated MAPK Activation, Cytokine Production, and Bacterial Clearance in Toll-Like Receptor 7/8 Primed Murine Macrophages
    Jaya Talreja, Lobelia Samavati · 2018 · Frontiers in Immunology
13. Tissue kallikrein regulates alveolar macrophage apoptosis early in influenza virus infection
    Mélia Magnen, Fabien Gueugnon, Agnès Petit‐Courty, Thomas Baranek, Damien Sizaret, Yambasu A. Brewah, Alison A. Humbles, Mustapha Si‐Tahar, Yves Courty · 2019 · American Journal of Physiology-Lung Cellular and Molecular Physiology
14. Lethal influenza infection: Is a macrophage to blame?
    Eric Scott Halstead, Zissis C. Chroneos · 2015 · Expert Review of Anti-infective Therapy
15. Influenza in High-Risk Hosts—Lessons Learned from Animal Models
    Rebekah Honce, Nicholas Wohlgemuth, Victoria Meliopoulos, Kirsty Renfree Short, Stacey Schultz‐Cherry · 2019 · Cold Spring Harbor Perspectives in Medicine
16. An ILC2-chitinase circuit restores lung homeostasis after epithelial injury
    Haerin Jung, Do-Hyun Kim, Roberto Efraín Díaz, J. Michael White, Summer Rucknagel, Lauryn Mosby, Yilin Wang, Sanjana Reddy, Emma S. Winkler, Ahmed O. Hassan et al. · 2024 · Science Immunology
17. Coinfection With Influenza A Virus and Klebsiella oxytoca: An Underrecognized Impact on Host Resistance and Tolerance to Pulmonary Infections
    Kayla M. Lee, Jenna Morris‐Love, Damien J. Cabral, Peter A. Belenky, Steven M. Opal, Amanda Mercedes Jamieson · 2018 · Frontiers in Immunology
18. Surfactant protein A alters endosomal trafficking of influenza A virus in macrophages
    Eric Yau, Linlin Yang, Yan Chen, Todd M. Umstead, Hannah Atkins, Zoe E. Katz, Jonathan Wilson Yewdell, Chintan K. Gandhi, Eric Scott Halstead, Zissis C. Chroneos · 2023 · Frontiers in Immunology
19. A critical role for the TLR signaling adapter Mal in alveolar macrophage-mediated protection against Bordetella pertussis
    Nicholas J. Bernard, Conor M. Finlay, Gillian M. Tannahill, Joseph P. Cassidy, Luke A.J. O'Neill, Kingston H. G. Mills · 2014 · Mucosal Immunology
20. Aggravated MRSA pneumonia secondary to influenza A virus infection is derived from decreased expression of IL‐1β
    Yunfeng Shi, Xiaohan Shi, Jingjing Liang, Jinmei Luo, Junhui Ba, Jianning Chen, Benquan Wu · 2020 · Journal of Medical Virology
21. A bacterial vesicle-based pneumococcal vaccine against influenza-mediated secondary Streptococcus pneumoniae pulmonary infection
    Saugata Majumder, Peng Li, Shreya Das, Tanvir Noor Nafiz, Sudeep Kumar, Guangchun Bai, Hazel Dellario, Haixin Sui, Ziqiang Guan, Roy Curtiss et al. · 2024 · Mucosal Immunology
22. PD-1 IC Inhibition Synergistically Improves Influenza A Virus-Mediated Oncolysis of Metastatic Pulmonary Melanoma
    Siarhei Sitnik, Dörthe Masemann, Rafael Leite Dantas, Viktor Wixler, Stephan Ludwig · 2020 · Molecular Therapy — Oncolytics
23. Too young to die? How aging affects cellular innate immune responses to influenza virus and disease severity
    Christopher M. Harpur, Mélanie A. Le Page, Michelle D. Tate · 2021 · Virulence
24. Type I IFN Signaling Is Essential for Preventing IFN-γ Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection
    Sunil Palani, Shruti Bansal, Atul K Verma, Christopher D. Bauer, Shengjun Shao, Md Bashir Uddin, Keer Sun · 2022 · The Journal of Immunology
25. Increased virus dissemination leads to enhanced lung injury but not inflammation during influenza-associated secondary bacterial infection
    Amanda Pfaff Smith, Lindey C. Lane, Ivan Ramirez-Zuniga, David J. Moquin, Peter Vogel, Amber M Smith · 2022 · FEMS Microbes
26. Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial Infection
    Ellyse Cipolla, Molin Yue, Kara L. Nickolich, Brydie R. Huckestein, Danielle Antos, Wei Chen, John F. Alcorn · 2022 · The Journal of Immunology
27. Influenza A Virus Exacerbates Group A Streptococcus Infection and Thwarts Anti-Bacterial Inflammatory Responses in Murine Macrophages
    Johann Aleith, Maria Brendel, Erik Weipert, Michael K. Müller, Daniel Schultz, Ko-Infekt Study Group, Brigitte Müller‐Hilke · 2022 · Pathogens
28. Progranulin Decreases Susceptibility to Streptococcus pneumoniae in Influenza and Protects against Lethal Coinfection
    Xiaofang Wang, Jun Yuan, Hong Wang, Ning Gan, Qun Zhang, Bichen Liu, Jingyao Wang, Zhaoche Shu, Lubei Rao, Xuemei Gou et al. · 2019 · The Journal of Immunology
29. Post-influenza bacterial infection: mechanisms of pathogenesis and advances in therapeutic strategies
    Biao Lei, Shun Wang, Linzhong Yu, Qinhai Ma · 2025 · Frontiers in Microbiology
30. Interleukin-4 protects mice against lethal influenza and Streptococcus pneumoniae co-infected pneumonia
    Peng Yang, Xiaofang Wang, Hong Wang, Wenchun Xu, Kaifeng Wu, Xuemei Go, Yibing Yin, Xuemei Zhang · 2021 · Clinical & Experimental Immunology
31. Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza
    Amber M. Smith · 2016 · Journal of Pharmacokinetics and Pharmacodynamics
32. Multicompartmental analysis of the murine pulmonary immune response by spectral flow cytometry
    Mary Y. Chang, Jourdan E. Brune, Michele C. Black, William A. Altemeier, Charles W. Frevert · 2023 · American Journal of Physiology-Lung Cellular and Molecular Physiology
33. Lung cell fates during influenza
    Brianna Jarboe, Maria Shubina, Ryan Andrew Langlois, David F. Boyd, Siddharth Balachandran · 2025 · Cell Research
34. Segmented filamentous bacteria reprogramming of alveolar macrophages limits postinfluenza bacterial pneumonia
    Vu L. Ngo, Carolin M. Lieber, Hirohito Abo, Michal Kuczma, Jun Zou, Richard Karl Plemper, Andrew T. Gewirtz · 2026 · Science Immunology
35. Respiratory viral infection and resolution of inflammation: Roles for specialized pro-resolving mediators
    Luciana P. Tavares, Julie Nijmeh, Bruce D. Levy · 2023 · Experimental Biology and Medicine
36. Amino acid 138 in the HA of a H3N2 subtype influenza A virus increases affinity for the lower respiratory tract and alveolar macrophages in pigs
    Matías Cárdenas, Brittany Seibert, Brianna Cowan, Ana Luiza Soares Fraiha, Silvia Carnaccini, L. Claire Gay, Flavio Cargnin Faccin, C. Joaquín Cáceres, Tavis K. Anderson, Amy L. Vincent Baker et al. · 2024 · PLoS Pathogens
37. HIF-1 regulates mitochondrial function in bone marrow-derived macrophages but not in tissue-resident alveolar macrophages
    Parker S. Woods, Rengül Çetin-Atalay, Angelo Y. Meliton, Kaitlyn A. Sun, Obada R. Shamaa, Kun Woo D Shin, Yufeng Tian, Benjamin Haugen, Robert B. Hamanaka, Gökhan M. Mutlu · 2025 · Scientific Reports
38. Lung tumor immunity: redirecting macrophages through infection-induced inflammation
    Öznur Aktay-Cetin, Soni Savai Pullamsetti, Susanne Herold, Rajkumar Savai · 2025 · Trends in Immunology
39. The past, present and future of RNA respiratory viruses: influenza and coronaviruses
    Vadim Makarov, Olga Riabova, Sean Ekins, Nikolay Pluzhnikov, Sergei Chepur · 2020 · Pathogens and Disease
40. Control of myeloid cell density in barrier tissues
    Florens Lohrmann, Aaron James Forde, P Merck, Philipp Henneke · 2020 · FEBS Journal
41. Pneumococcal carriage in children with COVID-19
    Kübra Aykaç, Yasemin Özsürekçi, Burcu Ceylan Cura Yayla, Kübra Evren, Sibel Laçinel Gürlevik, Pembe Derin Oygar, Mihriban Yücel, Ayse Esra Karakoc, Alpaslan Alp, Ali Bülent Cengiz et al. · 2021 · Human Vaccines & Immunotherapeutics
42. The Respiratory Microbiome in Paediatric Chronic Wet Cough: What Is Known and Future Directions
    Brianna Atto, Yitayal Anteneh, Seweryn Bialasiewicz, Michael Binks, Mostafa Hashemi, Jane E. Hill, Ruth B. Thornton, Jacob A. F. Westaway, Robyn L. Marsh · 2023 · Journal of Clinical Medicine
43. Unmasking the hidden impact of viruses on tuberculosis risk
    Fatoumatta Darboe, Josephine F. Reijneveld, David P. Maison, Leonardo Martínez, Sara Suliman · 2024 · Trends in Immunology
44. Harnessing Epigenetics: Innovative Approaches in Diagnosing and Combating Viral Acute Respiratory Infections
    Ankita Saha, Anirban Ganguly, Anoop Kumar, Nityanand Srivastava, Rajiv Pathak · 2025 · Pathogens
45. Survival during influenza-associated bacterial superinfection improves following viral- and bacterial-specific monoclonal antibody treatment
    Keven Mara Robinson, Krishnaveni Ramanan, Joshua M. Tobin, Kara L. Nickolich, Matthew J. Pilewski, Nicole L. Kallewaard, Bret R. Sellman, Taylor S. Cohen, John F. Alcorn · 2019 · JCI Insight
46. Viral infectious diseases severity: co-presence of transcriptionally active microbes (TAMs) can play an integral role for disease severity
    Aanchal Yadav, Rajesh Pandey · 2022 · Frontiers in Immunology
47. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells
    Alexander J. Vogel, Deborah M. Brown · 2015 · Frontiers in Immunology
48. Novel Therapies for Pneumonia-Associated Severe Asthma Phenotypes
    Angelica Papanicolaou, Hao Wang, Catherine Satzke, Ross Vlahos, Nick S. Wilson, Steven Bozinovski · 2020 · Trends in Molecular Medicine
49. Synergistic Protection against Secondary Pneumococcal Infection by Human Monoclonal Antibodies Targeting Distinct Epitopes
    Aaron D. Gingerich, Fredejah T. Royer, Anna L. McCormick, Anna Scasny, Jorge Eugenio Vidal, Jarrod J. Mousa · 2023 · The Journal of Immunology
50. Influenza A virus and related secondary bacterial infections
    Elham Sheykhsaran, Nima Hemmat, Hossein Bannazadeh Baghi · 2018 · Reviews in Medical Microbiology
51. Modeling the within-host co-infection of influenza A virus and pneumococcus
    Fulgensia Kamugisha Mbabazi, J. Mugisha, Mark E. M. Kimathi · 2018 · Applied Mathematics and Computation
52. Gammaherpesvirus Alters Alveolar Macrophages According to the Host Genetic Background and Promotes Beneficial Inflammatory Control over Pneumovirus Infection
    Gautier Gilliaux, Daniel J.-M. Desmecht · 2022 · Viruses
53. Macrophage Depletion in CCR2−/− Mice Delays Bacterial Clearance and Enhances Neutrophil Infiltration in an Acute Otitis Media Model
    Dong Gu Hur, Arwa Kurabi, Hyun Woo Lim, Meghan Spriggs, Kwang K. Pak, Allen Frederic Ryan · 2020 · The Journal of Infectious Diseases
54. Prevalence of bacterial pathogens and potential role in COVID-19 severity in patients admitted to intensive care units in Brazil
    Fabíola Marques de Carvalho, Leandro Nascimento Lemos, Luciane Prioli Ciapina, Rennan Garcias Moreira, Alexandra Lehmkuhl Gerber, Ana Paula C Guimarães, Tatiani Fereguetti, Virgínia Antunes de Andrade Zambelli, Renata Eliane de Ávila, Tailah Bernardo de Almeida et al. · 2020 · medRxiv
55. The impact of secondary infections in COVID-19 critically ill patients
    Federica Murgia, Maura Fiamma, Silvia Serra, Sabrina Olla, Maria Cristina Garau, Eleonora E. Cocco, Lorena Lorefice, Sandro Muntoni, Peppino Paffi, Stefano Porru et al. · 2022 · Journal of Infection
56. Immune predisposition drives susceptibility to pneumococcal pneumonia after mild influenza A virus infection in mice
    Sunil Palani, Md Bashir Uddin, Michael C. McKelvey, Shengjun Shao, Keer Sun · 2023 · Frontiers in Immunology
57. Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumonia
    Marilia Sanches Santos Rizzo Zuttion, Tanyalak Parimon, Stephanie A. Bora, Changfu Yao, Katherine Lagree, Catherine A. Gao, Richard G. Wunderink, Georgios D. Kitsios, Alison Morris, Yingze Zhang et al. · 2024 · Journal of Clinical Investigation
58. Inflammation-Induced Metastatic Colonization of the Lung Is Facilitated by Hepatocyte Growth Factor-Secreting Monocyte-Derived Macrophages
    Arif A. Arif, Yu-Hsuan Huang, Spencer A. Freeman, Jawairia Atif, Pamela Dean, Jacqueline C.Y. Lai, Marie‐Renée Blanchet, Kimberly C. Wiegand, Kelly Marshall McNagny, T. Michael Underhill et al. · 2021 · Molecular Cancer Research
59. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza
    Kazuyuki Mimura, Soichiro Kimura, Chiaki Kajiwara, Sho Nakakubo, Matthew A Schaller, Yoshikazu Ishii, Theodore J. Standiford, Steven L. Kunkel, Kazuhiro Tateda · 2020 · Microbes and Infection
60. Dynamic Pneumococcal Genetic Adaptations Support Bacterial Growth and Inflammation during Coinfection with Influenza
    Amanda Pfaff Smith, Lindey C. Lane, Tim van Opijnen, Stacie Woolard, Robert Carter, Amy Iverson, Corinna Burnham, Peter Vogel, Dana Roeber, Gabrielle M. Hochu et al. · 2021 · Infection and Immunity
61. The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic
    Federica Murgia, Maura Fiamma, Silvia Serra, Giulia Marras, Raul Argiolas, Chiara Mattana, Maria Grazia Mattu, Maria Cristina Garau, Sonia Doneddu, Sabrina Olla et al. · 2022 · Clinical and Experimental Medicine
62. Sodium–Glucose Cotransporter-2 Inhibitor, Empagliflozin, Suppresses the Inflammatory Immune Response to Influenza Infection
    Nicholas J Constantinesco, Baskaran Chinnappan, Louis DeVito, Crystal Moras, Sashwath Srikanth, María de la Luz García-Hernández, Javier Rangel‐Moreno, Radha Gopal · 2023 · ImmunoHorizons
63. Viral-Bacterial Interactions in Childhood Respiratory Tract Infections
    Alicia A. Annamalay, Peter Neils Le Souëf · 2017 · Springer eBooks
64. The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections
    Miriam Klausberger, Ирина Анатольевна Ленева, Irina N. Falynskova, Kirill Vasilev, А. В. Поддубиков, Claudia Lindner, Карташова Надежда Павловна, О. А. Свитич, Marina Stukova, Reingard Maria Grabherr et al. · 2019 · Vaccines
65. The role of serum circulating microbial toxins in severity and cytokine storm of COVID positive patients
    Arezoo Fallah, Hamid Sedighian, Elham Behzadi, Seyed Asghar Havaei, Reza Kachuei, Abbas Ali Imani Fooladi · 2022 · Microbial Pathogenesis
66. Mechanisms of Predisposition to Pneumonia
    Anthony J. Infante, Jonathan A. McCullers, Carlos Javier Orihuela · 2015 · Elsevier eBooks
67. Dynamics between infectious diseases with two susceptibility conditions: A mathematical model.
    Juan Pablo Gutiérrez-Jara, Fernando Córdova‐Lepe, María Teresa Muñoz-Quezada · 2019 · Mathematical Biosciences
68. Pregnancy enhances antiviral immunity independent of type I IFN but dependent on IL-17–producing γδ + T cells in the nasal mucosa
    Julia Chronopoulos, Erwan Pernet, Kim A. Tran, Toby K. McGovern, Arina Morozan, Sadie Wang, Oscar Tsai, Kosuke Makita, Maziar Divangahi, James G. Martin · 2024 · Science Advances
69. Intranasal exposure to commensal bacterium Rothia mucilaginosa protects against influenza A virus infection
    Ana Raquel Maia, Loïc Gonzalez, Badreddine Bounab, Lucia C. Grassi, Coralie Mousset, Gaëlle Fromont, Adeline Cezard, Pieter Sicco Hiemstra, Thomas Baranek, Christophe Paget et al. · 2025 · Antiviral Research
70. Respiratory dysbiosis as prognostic biomarker of disease severity for adults with community-acquired pneumonia requiring mechanical ventilation
    Loreto Vidaur, Amalur Guridi, Oihana Leizaola, Jokin Marin, Jordi Rello, Cristina Sarasqueta, Ane Sorarrain, José María Marimón · 2025 · Pneumonia
71. Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating Factor Receptor Expression
    Sue‐Jane Lin, Kai‐Min Lin, Shi-Yo Jill Chen, Chia‐Chi Ku, Chen‐Wei Huang, Chi‐Hsiang Huang, Michael Gale, Ching-Hwa Ann Tsai · 2023 · Journal of Virology
72. The host transcriptional response to superinfection by influenza A virus and Streptococcus pneumoniae
    Ofir Cohn, Gal Yankovitz, Michal Mandelboim, Naama Peshes‐Yaloz, Rachel Brandes, Eran Bacharach, Irit Gat‐Viks · 2024 · mSystems
73. The W-Shaped Mortality-Age Distribution of Novel H1N1 Influenza Virus Helps Reconstruct the Second Wave of Pandemic 1918 Spanish Flu
    Lai KY Wing Yiu · 2015 · Journal of Pulmonary & Respiratory Medicine
74. Macrophage CD14 impacts immune defenses against influenza virus in allergic hosts
    Maneesha Palipane, John D. Snyder, Kim S. LeMessurier, Anna K. Schofield, Stacie Woolard, Amali Eashani Samarasinghe · 2018 · Microbial Pathogenesis
75. Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection
    Christopher M. Harpur, Alison C. West, Mélanie A. Le Page, Maggie Lam, Christopher Hodges, Osezua Oseghale, Andrew J Gearing, Michelle D. Tate · 2023 · Clinical & Translational Immunology
76. Potential mediators of in ovo delivered double stranded (ds) RNA-induced innate response against low pathogenic avian influenza virus infection
    Hanaa Ahmed-Hassan, Mohamed Sarjoon Abdul-Cader, Upasama De Silva Senapathi, Maha Ahmed Sabry, Eman Hamza, Éva Nagy, Shayan Sharif, Mohamed Faizal Abdul-Careem · 2018 · Virology Journal
77. Clinical and Microbiological Features of Asymptomatic SARS-CoV-2 Infection and Mild COVID-19 in Seven Crewmembers of a Cruise Ship
    Takayuki Hoshiyama, Tatsuhiko Wada, Shin Nihonyanagi, Ryo Kameda, Minako Yamaoka‐Tojo, Michinari Fukuda, Jyunya Ako, Kunihiro Yamaoka, Yoko Takayama · 2020 · Internal Medicine
78. Transkingdom Interactions Important for the Pathogenesis of Human Viruses
    Andrew T. Nishimoto, Nicholas Wohlgemuth, Jason W. Rosch, Stacey Schultz‐Cherry, Valerie A. Cortez, Hannah M. Rowe · 2020 · The Journal of Infectious Diseases
79. A PCR-based method for quantifying neutrophils in human nasal secretions
    Matthew C. Morris, M. Nadeem Khan, Michael E. Pichichero · 2017 · Journal of Immunological Methods
80. TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection
    Angela Choi, Ioanna Christopoulou, Xavier Saelens, Adolfo García‐Sastre, Michael Schotsaert · 2019 · Vaccines
81. Evaluating the evidence for GM-CSF as a host-directed therapy in respiratory infections
    Camille David, Charles Verney, Mustapha Si‐Tahar, Antoine Guillon · 2025 · Cytokine
82. Influenza virus and Staphylococcus aureus super-infection disrupts spatially coordinated cellular immunity in the mouse lung
    Tianhao Liu, Leigh M. Miller, Brooke P. Dresden, Chongyue Zhao, Yogesh Pillai, Angel Rangel-Garcia, María de la Luz García-Hernández, Javier Rangel‐Moreno, Wei Chen, John F. Alcorn · 2025 · Communications Biology
83. Human monoclonal antibodies protect against viral-mediated pneumococcal superinfection
    Aaron D. Gingerich, Lauren Mahoney, Anna L. McCormick, Rose J. Miller, Jarrod J. Mousa · 2024 · Frontiers in Immunology
84. Bacterial and Viral Co-Infections in COVID-19 Patients: Etiology and Clinical Impact
    Ivelina T. Trifonova, Ivelina T. Trifonova, Neli Korsun, Victoria Levterova, Petar Velikov, Silvia Voleva, Ivan Ivanov, Daniel Toshkov Ivanov, Ralitsa Yordanova, Tatiana Tcherveniakova et al. · 2024 · Biomedicines
85. Type I Interferon Targets Alveolar Macrophages to Promote Bacterial Pneumonia after Viral Infection
    Sunil Palani, Md Bashir Uddin, Michael C. McKelvey, Shengjun Shao, Wenzhe Wu, Xiaoyong Bao, Jiaren Sun, Keer Sun · 2025 · American Journal of Respiratory Cell and Molecular Biology
86. What came first, the virus or the egg: Innate immunity during viral coinfections
    Meagan D. Rippee‐Brooks, Riley N. Marcinczyk, Christopher R. Lupfer · 2020 · Immunological Reviews
87. Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice
    Frank van Someren Gréve, Koenraad F. van der Sluijs, Anita M. Tuip‐de Boer, Marcus Josephus Schultz, Menno D. de Jong, Nicole Petra Juffermans · 2018 · Journal of Medical Virology
88. TNF superfamily member 14 drives post-influenza depletion of alveolar macrophages, enabling secondary pneumococcal pneumonia
    Christina Malainou, Christin Peteranderl, Maximiliano Ruben Ferrero, Ana Ivonne Vazquez‐Armendariz, Ioannis Alexopoulos, Katharina Franz, Klara Knippenberg, Julian Better, Mohammad Estiri, Cheng‐Yu Wu et al. · 2025 · Journal of Clinical Investigation
89. Potential of biomarkers of ageing in predicting severity of influenza virus infection and vaccination efficacy
    Jing Yang, Wei Ren, Yi Ren, Ting Yu, Liaqat Ali · 2025 · npj Aging
90. Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments
    Yaron Vagima, David Gur, Noam Erez A, Hagit Achdout, Moshe Aftalion, Yinon Levy, Ayelet Zauberman, Avital Tidhar, Hila Gutman, Shlomi Lazar et al. · 2020 · Scientific Reports
91. Prevalence and Clinical Disease Severity of Respiratory Coinfections During the Coronavirus Disease 2019 Pandemic
    Maxwell D. Weidmann, Gregory J. Berry, Daniel A. Green, Fann Wu · 2022 · Advances in Molecular Pathology
92. The Influenza-Induced Pulmonary Inflammatory Exudate in Susceptible Tpl2-Deficient Mice Is Dictated by Type I IFN Signaling
    Krishna Latha, Yesha Patel, Sanjana Rao, Wendy Tharpe Watford · 2022 · Inflammation
93. Preventive nasal administration of flagellin restores antimicrobial effect of gentamicin and protects against a multidrug-resistant strain of Pseudomonas aeruginosa
    Ana Raquel Maia, Adeline Cezard, Delphine Fouquenet, Virginie Vasseur, Benoit Briard, Jean‐Claude Sirard, Mustapha Si‐Tahar, Virginie Hervé · 2024 · Antimicrobial Agents and Chemotherapy
94. B cell deficiency induces cytotoxic memory CD8+ T cells during influenza-associated bacterial pneumonia
    Leigh M. Miller, Alexis M. Duray, Ellyse Cipolla, Flávia Rago, Brooke P. Dresden, Kristen L. Parenteau, Abhigya Gupta, John F. Alcorn · 2025 · Journal of Clinical Investigation
95. PostInfluenza bacterial infections: Epidemiology, mechanistic insights and emerging treatment approaches
    Yueying Chen, Hong Li, Jingwen Mu, Yanchun Peng, Pasqualina D’Ursi, Keda Chen, Yuejuan Zheng · 2026 · Journal of Infection and Public Health
96. Host-pathogen interaction in community-acquired pneumonia: a focus on the immune response
    Antonio Maria Ferriero, Raffaella Di Lella, Chiara Farroni, Alessandra Aiello, Antonino Giarratano, Matilde Todaro, Maria Grazia Bocci, Emanuele Nicastri, Delia Goletti · 2026 · Frontiers in Cellular and Infection Microbiology
97. Alternaria alternata Accelerates Loss of Alveolar Macrophages and Promotes Lethal Influenza A Infection
    Caroline M. Percopo, Michelle Ma, Eric Mai, Jamie L. Redes, Laura S Kraemer, Mahnaz Minai, Ian N. Moore, Kirk M. Druey, Helene F. Rosenberg · 2020 · Viruses
98. Progress in the application of organoids for exploring the relationship between macrophages and various lung diseases
    Wu Jiawang, Ting Liu, Xinting Zhang, Chang F. Qu, Juan Wu, Shuanglan Xu, Jiao Yang, Xiqian Xing · 2025 · Biofabrication
99. Virus-associated fungal infections and lost immune resistance
    Nicole Sarden, Bryan G. Yipp · 2023 · Trends in Immunology
100. Influenza-Induced Activation of Recruited Alveolar Macrophages During the Early Inflammatory Phase Drives Lung Injury and Lethality
     Clarissa M. Koch, Kishore Reddy Anekalla, Yuan‐Shih Hu, Jennifer M. Davis, Mark Ciesielski, Gaurav T. Gadhvi, Shang-Yang Chen, Margaret Turner, Yuan Cheng, Bria M. Coates et al. · 2022 · SSRN Electronic Journal